Kerecis is an Icelandic company that pioneers the use of fish skin and fatty acids in the cellular-therapy and regenerative-medicine markets. Their patented technologies utilize fatty-acid-rich products to protect and regenerate human tissues. They develop and manufacture medical products for human-tissue repair, authorized for sale in Europe, the United States, and other jurisdictions. With a mission to become a world leader in regenerating damaged human tissues, Kerecis aims to extend human life by supporting the body's own ability to protect and regenerate tissues.

Kerecis

Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular therapy and regenerative medicine market. The fatty-acid rich (including Omega3) products from the company's patented technologies enable the body to regenerate tissues, rather than simply repair them and risk scarring.The Kerecis products, which are based on Omega3 rich fish skin, are currently being used to regenerate tissue in trauma and chronic wounds such as burns and diabetic wounds. Kerecis is also developing products for areas such as oral surgery, plastic surgery and neurological applications.The vision of Kerecis is to extend human life by supporting the body’s own ability to regenerate. The Kerecis mission is to become the world leader in regenerating damage of the human body by sustainably harnessing nature’s own remedies.

COM:KERECIS

Kerecis

locale

market

industry

website

crunchbase

linkedin

founding date

peer of

Metrics